Abreu,Luiz Maurino. Clinical Significance of Statistical Differences. Arq. Bras. Cardiol. [online]. 2020, vol. 114, n. 2, [cited 2025-09-07], pp.281-283. Available from: <https://abccardiol.org/en/short-editorial/clinical-significance-of-statistical-differences/>. ISSN 0066-782X.
Figure 1
Dyslipidemia as a central element in atherosclerotic cardiovascular disease. ASCVD: atherosclerotic cardiovascular disease; LDL-C: low-density lipoprotein cholesterol. Limitations of statin-based therapy (non-exhaustive) include suboptimal LDL-C goal attainment, statin-associated adverse effects that may affect adherence, and potential drug interactions. Residual risk reflects the involvement of multiple underlying pathways.
